Skip to content

Modulation of the intestinal microbiome, and its effects on endurance exercise capacity in moderately trained individuals

Modulation of the intestinal microbiome, and its effects on endurance exercise capacity in moderately trained individuals - Intestinal microbiome modulation and endurance exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49125
Enrollment
34
Registered
2020-08-27
Start date
2021-01-23
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spierfunctie exercise performance

Interventions

The intervention will be carried out with 5 different prebiotics supplements suitable for human consumption. Thefollowing prebiotics are selected (commercially available): 1. Dietary intake or galac

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18- 40 years 2. 18.5

Exclusion criteria

Exclusion criteria: 1. Smoking 2. Performing regular resistance training (3+ times per week, carrying out progressive training) 3. Subject following an overly imbalanced or restrictive diet as per nutritional advice 4. Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be detrimental for the participants safety or potentially interfering with the study procedures and/or study outcome 5. Hypertension (according to WHO criteria) and/or cardiovascular disease 6. Abdominal surgery interfering with gastrointestinal function, upon judgement of the medical doctor, who will decide in-or exclusion based on the surgery applied 7. Participants who received antibiotics in the previous 90 days to the start of study 8. Use of other medication will be reviewed by a medical doctor, who will decide on in- or exclusion based on the drug(s) used 9. Use of laxatives within 14 days prior to the study 10. Using medications for gastric or intestinal complaints 11. Drug use, interfering with any of the outcome parameters of this study; to be decided by the person who is medically responsible for this study 12. Self-admitted lactose intolerance 13. Having donated blood in the 3 months prior to the study 14. Administration of probiotic or prebiotic supplements, investigational drugs or participation in any scientific intervention study, which may interfere with this study (to be decided by the principle investigator), in the 14 days prior to the study 15. History of side effects towards intake of prebiotic supplements 16. Use of proton pump inhibitors

Design outcomes

Primary

MeasureTime frame
The most important parameter is the outcome of the exercise test until exhaustion.

Secondary

MeasureTime frame
- the fecal microbiota - biomarkers of metabolic health; fasting glucose, insulin and SCFA - SCFA concentration in the droppings - permeability of the intestines after a single exercise test - permeability of the intestines after intervention

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)